Escherichia coli O25b-ST131 and O16-ST131 causing urinary tract infection in women in Changsha, China: molecular epidemiology and clinical characteristics

References

• Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113 Suppl 1A:5S–13S. doi:10.1016/S0002-9343(02)01054-9
   PubMed Web of Science ®Google Scholar
• Foxman B, Barlow R, D’Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509–515. doi:10.1016/s1047-2797(00)00072-7
   Web of Science ®Google Scholar
• Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80(3):331–333. doi:10.2105/ajph.80.3.3312305919
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang H, Wang Y, et al. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014. BMC Infect Dis. 2017;17(1):192. doi:10.1186/s12879-017-2296-x28264656
   PubMed Web of Science ®Google Scholar
• Zhang H, Kong H, Yu Y, et al. Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. BMC Infect Dis. 2018;18(1):493. doi:10.1186/s12879-018-3405-130268102
   PubMed Web of Science ®Google Scholar
• Pitout JD. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol. 2012;3:9. doi:10.3389/fmicb.2012.0000922294983
   PubMed Web of Science ®Google Scholar
• Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27(3):543–574. doi:10.1128/CMR.00125-13
   Web of Science ®Google Scholar
• Gibreel TM, Dodgson AR, Cheesbrough J, et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother. 2012;67(2):346–356. doi:10.1093/jac/dkr45122028202
   PubMed Web of Science ®Google Scholar
• Brisse S, Diancourt L, Laouánan C, et al. Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol. 2012;50(9):2974–2981. doi:10.1128/jcm.00919-1222760036
   PubMed Web of Science ®Google Scholar
• Banerjee R, Strahilevitz J, Johnson JR, et al. Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol. 2013;34(9):947–953. doi:10.1086/67172523917909
   PubMed Web of Science ®Google Scholar
• Li B, Lu Y, Lan F, He Q, Li C, Cao Y. Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital. Antimicrob Resist Infect Control. 2017;6:118. doi:10.1186/s13756-017-0274-029167743
   PubMed Web of Science ®Google Scholar
• Qin X, Hu F, Wu S, et al. Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. PLoS One. 2013;8(4):e61169. doi:10.1371/journal.pone.006116923593422
   PubMed Web of Science ®Google Scholar
• Platell JL, Cobbold RN, Johnson JR, et al. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother. 2011;55(8):3782–3787. doi:10.1128/AAC.00306-1121646486
   PubMed Web of Science ®Google Scholar
• Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014;58(9):4997–5004. doi:10.1128/AAC.02824-1424867985
   PubMed Web of Science ®Google Scholar
• Dahbi G, Mora A, López C, et al. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum beta-lactamases. Int J Antimicrob Agents. 2013;42(4):347–351. doi:10.1016/j.ijantimicag.2013.06.01723992646
   PubMed Web of Science ®Google Scholar
• Blanc V, Leflon-Guibout V, Blanco J, et al. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b: H4and O16: H5 ST131 strains. J Antimicrob Chemother. 2014;69(5):1231–1237. doi:10.1093/jac/dkt51924402502
   PubMed Web of Science ®Google Scholar
• Zhong YM, Liu WE, Liang XH, et al. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China. J Antimicrob Chemother. 2015;70(8):2223–2227. doi:10.1093/jac/dkv11425957581
   PubMed Web of Science ®Google Scholar
• Ho PL, Chu YP, Lo WU, et al. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients. J Med Microbiol. 2015;64(Pt 3):243–247. doi:10.1099/jmm.0.00001225587081
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-sixth Informational Supplement M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• Jia H, Li W, Hou T, et al. The attributable direct medical cost of healthcare associated infection caused by multidrug resistance organisms in 68 hospitals of China. Biomed Res Int. 2019;2019:7634528. doi:10.1155/2019/763452830949509
   PubMed Web of Science ®Google Scholar
• Clermont O, Christenson JK, Denamur E, et al. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5(1):58–65. doi:10.1111/1758-2229.1201923757131
   PubMed Web of Science ®Google Scholar
• Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181(1):261–272. doi:10.1086/31521710608775
   PubMed Web of Science ®Google Scholar
• Blanco J, Mora A, Mamani R, et al. Four main virotypes among extended-spectrum-beta-lactamase-producing isolates of Escherichia coli O25b: H4-B2-ST131:bacterial, epidemiological, and clinical characteristics. J Clin Microbiol. 2013;51(10):3358–3367. doi:10.1128/JCM.01555-1323926164
   PubMed Web of Science ®Google Scholar
• Johnson JR, Clermont O, Johnston B, et al. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol. 2014;52(5):1358–1365. doi:10.1128/JCM.03502-1324501035
   PubMed Web of Science ®Google Scholar
• Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother. 2006;57(1):154–155. doi:10.1093/jac/dki41216284100
   PubMed Web of Science ®Google Scholar
• Grobner S, Linke D, Schutz W, et al. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase- producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol. 2009;58(Pt 7):912–922. doi:10.1099/jmm.0.005850-019502377
   PubMed Web of Science ®Google Scholar
• Weissman SJ, Johnson JR, Tchesnokova V, et al. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol. 2012;78(5):1353–1360. doi:10.1128/AEM.06663-1122226951
   PubMed Web of Science ®Google Scholar
• Leflon-Guibout V, Jurand C, Bonacorsi S, et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother. 2004;48(10):3736–3742. doi:10.1128/AAC.48.10.3736-3742.200415388428
   PubMed Web of Science ®Google Scholar
• Johnson JR, Tchesnokova V, Johnston B, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis. 2013;207(6):919–928. doi:10.1093/infdis/jis93323288927
   PubMed Web of Science ®Google Scholar
• Kim HB, Park CH, Kim CJ, et al. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009;53(2):639–645. doi:10.1128/AAC.01051-0819064896
   PubMed Web of Science ®Google Scholar
• Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157: H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3(1):59–67. doi:10.1089/fpd.2006.3.5916602980
   PubMed Web of Science ®Google Scholar
• Banerjee R, Johnston B, Lohse C, et al. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol. 2013;34(4):361–369. doi:10.1086/66986523466908
   PubMed Web of Science ®Google Scholar
• Kim YA, Lee K, Chung JE. Risk factors and molecular features of sequence type (ST) 131 extended-spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections. BMC Infect Dis. 2018;18(1):250. doi:10.1186/s12879-018-3168-829859045
   PubMed Web of Science ®Google Scholar
• Johnson JR, Johnston B, Clabots C, et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010;51(3):286–294. doi:10.1086/65393220572763
   PubMed Web of Science ®Google Scholar
• Vimont S, Boyd A, Bleibtreu A, et al. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One. 2012;7(9):e46547. doi:10.1371/journal.pone.004654723029548
   PubMed Web of Science ®Google Scholar
• Johnson JR, Porter SB, Zhanel G, et al. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun. 2012;80(4):1554–1562. doi:10.1128/IAI.06388-1122311928
   PubMed Web of Science ®Google Scholar
• Paul S, Linardopoulou EV, Billig M, et al. Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli. J Bacteriol. 2013;195(2):231–242. doi:10.1128/JB.01524-1223123908
   PubMed Web of Science ®Google Scholar
• Weissman SJ, Beskhlebnaya V, Chesnokova V, et al. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli fimH adhesin. Infect Immun. 2007;75(7):3548–3555. doi:10.1128/iai.01963-0617502398
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Yamamoto M, Nagao M, et al. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-beta-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. Antimicrob Agents Chemother. 2013;57(10):4736–4742. doi:10.1128/AAC.00641-1323856781
   PubMed Web of Science ®Google Scholar
• Kudinha T, Johnson JR, Andrew SD, et al. Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J Clin Microbiol. 2013;51(10):3270–3276. doi:10.1128/JCM.01315-1323885001
   PubMed Web of Science ®Google Scholar